Orthofix Medical (Orthofix Medical) Operating Cash Flow per Share : $-1.27 (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Orthofix Medical Operating Cash Flow per Share?

Orthofix Medical's operating cash flow per share for the three months ended in Dec. 2023 was $-0.18. Orthofix Medical's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.27.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Orthofix Medical's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Orthofix Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 127.70% per year. The lowest was -43.70% per year. And the median was 4.40% per year.

OFIX's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 3.65
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Orthofix Medical Operating Cash Flow per Share Historical Data

The historical data trend for Orthofix Medical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Operating Cash Flow per Share Chart

Orthofix Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.70

3.83

0.94

-0.58

-1.25

Orthofix Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.12	-0.95	-0.15	0.01	-0.18

Competitive Comparison of Orthofix Medical's Operating Cash Flow per Share

For the Medical Devices subindustry, Orthofix Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orthofix Medical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Price-to-Operating-Cash-Flow falls into.

Orthofix Medical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Orthofix Medical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-45.753	/	36.729
	=	-1.25

Orthofix Medical's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-6.694	/	37.153
	=	-0.18

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.27

Orthofix Medical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Orthofix Medical (Orthofix Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

OM2:Germany

Address

3451 Plano Parkway, Lewisville, TX, USA, 75056

Website

https://www.orthofix.com

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Executives

James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha	officer: CECO & Interim CLO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie	officer: VP, Controller, Interim CFO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny	officer: President of Global Spine	C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic	officer: CFO	C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine	director, officer: President & CEO	7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran	officer: Chief Legal Officer	6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West	director	C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci	director	7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik	director
Rice Doug	officer: CFO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting	officer: Chief Legal Officer	3451 PLANO PARKWAY, LEWISVILLE TX 75056